CEA (Carcinoembryonic Antigen) is a blood colorectal tumor marker test that widely used in a clinical setting. The aim of this research is to assess the correlation between carcinoembryonic antigen (CEA) and the degree of tumor differentiation, and between obstruction and age of patients and colorectal adenocarcinoma. This research was a retrospective analytic observational study with a cross-sectional approach. This research used medical record of colorectal carcinoma patients without other malignancy obtained from Wahidin Sudirohusodo Hospital having complete medical records from 2015 to 2017. Initial anamnesis, the result of radiology, laboratory, and the result of pathology were obtained and analyzed using univariate and bivariate analy...
Summary: Pretreatment and serial posttreatment carcino embryonic antigen (CEA) serum levels were stu...
Carcinoembryonic antigen (CEA) in the serum and the tumour tissue of colorectal cancer (CRC) patient...
INTRODUCTION: The carcinoembryonic antigen, CEA, is the tumor marker most used in colorectal patient...
Colorectal cancer is the fourth commonest cancer worldwide. Around two-thirds of a million people wi...
Background: Carcinoembryonic Antigen (CEA) is the most commonly used tumor marker for colorectal can...
Histopathological grading, which represents the degree of histopathological differentiation, is ofte...
Background: Colorectal cancer is the third most common malignancy worldwide and the second most leth...
The staging can be used as one of the prognostic factors providing a clinical picture of the patient...
Adenocarcinoma of the rectum is the most common colorectal cancer in Indonesia. This cancer has the ...
BACKGROUND Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 are tumor markers for ...
Background: Colorectal cancer is a malignancy that originates from the colon tissue, which consists ...
Background: Colorectal cancer is one of cancer that has a high mortality rate. Cancer is associated ...
Background: This study aimed to evaluate the prognostic significance of preoperative, postoperative,...
Background: Testing for carcino-embryonic antigen (CEA) in the blood is a recommended part of follow...
Background Testing for carcino-embryonic antigen (CEA) in the blood is a recommended part of follow-...
Summary: Pretreatment and serial posttreatment carcino embryonic antigen (CEA) serum levels were stu...
Carcinoembryonic antigen (CEA) in the serum and the tumour tissue of colorectal cancer (CRC) patient...
INTRODUCTION: The carcinoembryonic antigen, CEA, is the tumor marker most used in colorectal patient...
Colorectal cancer is the fourth commonest cancer worldwide. Around two-thirds of a million people wi...
Background: Carcinoembryonic Antigen (CEA) is the most commonly used tumor marker for colorectal can...
Histopathological grading, which represents the degree of histopathological differentiation, is ofte...
Background: Colorectal cancer is the third most common malignancy worldwide and the second most leth...
The staging can be used as one of the prognostic factors providing a clinical picture of the patient...
Adenocarcinoma of the rectum is the most common colorectal cancer in Indonesia. This cancer has the ...
BACKGROUND Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 are tumor markers for ...
Background: Colorectal cancer is a malignancy that originates from the colon tissue, which consists ...
Background: Colorectal cancer is one of cancer that has a high mortality rate. Cancer is associated ...
Background: This study aimed to evaluate the prognostic significance of preoperative, postoperative,...
Background: Testing for carcino-embryonic antigen (CEA) in the blood is a recommended part of follow...
Background Testing for carcino-embryonic antigen (CEA) in the blood is a recommended part of follow-...
Summary: Pretreatment and serial posttreatment carcino embryonic antigen (CEA) serum levels were stu...
Carcinoembryonic antigen (CEA) in the serum and the tumour tissue of colorectal cancer (CRC) patient...
INTRODUCTION: The carcinoembryonic antigen, CEA, is the tumor marker most used in colorectal patient...